Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma with Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies
Year: 2019
Type: article
Source: Liver Cancer
DOI: 10.1159/000503254
Author: Masatoshi Kudo
Institutions: Kindai University Hospital, Kindai University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,590
OpenAlex ID: W2976901627
